Here, we report the feasibility, safety, and efficacy of neoadjuvant PD-L1 and TGF-β blockade with bintrafusp alfa in patients with newly diagnosed HPV-unrelated HNSCC. The gene discussed is TGFB1; the disease is head and neck squamous cell carcinoma.